Cubist Systematic Strategies, LLC Travere Therapeutics, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 103,933 shares of TVTX stock, worth $1.92 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
103,933
Previous 346,068
69.97%
Holding current value
$1.92 Million
Previous $2.84 Million
48.87%
% of portfolio
0.01%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding TVTX
# of Institutions
190Shares Held
84.7MCall Options Held
681KPut Options Held
346K-
Armistice Capital, LLC New York, NY7.65MShares$141 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$141 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$127 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$86.5 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$80.2 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.19B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...